ClinicalTrials.gov
public full text
Public Domain
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prognostic Factors Keeping Track for COVID-19 Pneumonia#674828
- CT Scores Predict Mortality in 2019-nCoV Pneumonia#803160
- Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia#966998
- Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients#1008294
- Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients#979226
Record · ID 279541
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive